Thursday, February 24, 2011

Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)


Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)

Drug delivery is evolving at a rapid rate with new drug product formulations being discovered frequently. Advanced drug delivery deals with developing solutions for new entities in therapeutic pharmacology such as protein and peptides and other novel compounds targeting drugs to specific disease sites including gene therapy. Treatments for chronic conditions and growth in patient-administered drugs are factors leading to greater focus on ease-of-use and convenience.
Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies) details the types of drug delivery systems, technologies and products utilizing advanced drug delivery systems The report describes the industry, its relationship to various healthcare channels, and the trends for the future.
The advanced drug delivery market is two-fold. First of all it identifies drug delivery technology Secondly, it identifies products in the pharmaceutical arena that utilize those drug delivery technologies. Because drug delivery technology is an integral part of sales of pharmaceuticals and drug delivery technology cannot exist without pharmaceuticals, revenues have been reported that include pharmaceutical sales. This report will provide market data that includes the pharmaceutical revenues of those products that utilize advanced drug delivery.
In this report, the advanced drug delivery market is divided into three main segments and market estimates are provided for indications within each category:
  • Liposome Drug Delivery (by Indication – Fungal Infections Cancer, Others)
  • Polymer Drug Delivery (by Indication – Cancer, Neutropenia, Hepatitis, Contraception, Schizophrenia, Acromegaly and Others)
  • Monoclonal Antibodies Drug Delivery (by Indication – Arthritis, Cancer, Multiple Sclerosis, Macular Degeneration, Respiratory Syncytial Virus, Others)
The following types of polymer delivery drugs are segmented within this report.
  • PEGylated Delivery
  • Emulsuion Delivery
  • Injectable Delivery
  • Nanoparticle Delivery
  • Others
A wide range of trends and issues that will impact the advance drug delivery market are discussed in the report including the current state of biotechnolgy expansion, molecular imprinted polymers, hot-melt extrusion, metallofullerenes, nanotechnology advancements and other emerging Drug Delivery technologies not yet on the market.
The following companies are profiled in the report:
  • Alkermes, Inc.
  • ALZA Corporation
  • AP Pharma
  • Centocor Ortho Biotech, Inc.
  • Eisai , Inc
  • Elan Corporation, Plc
  • EnColl Corporation, Inc.
  • Enzon Pharmaceuticals, Inc
  • Gilead Sciences, Inc.
  • Nektar Therapeutics
  • PDL BioPharma
  • pSivida Corp
  • SurModics, Inc
  • Tolmar, Inc
The research conducted by Kalorama Information included comprehensive research of primary and secondary sources such as interviews with company executives, company literature, databases, investment reports, and medical and business journals. New technologies, market developments, and research and development trends and expenditures were identified through patent and data-based searches, as well as via interviews with key personnel. Person-to-person and telephone interviews were the primary method of gathering information. E-mail correspondence was also used in the interview process. Interviews with 24 key industry officials, trade association spokespersons, consultants, healthcare providers, and government personnel were compiled to form the primary basis of information – particularly revenue and market share data- presented in this report.
All market data pertains to the worldwide market at the manufacturers’ level and was measured in U.S. dollars. The base year for data was 2010. Historical data are provided for 2006 through 2009, with forecast data provided for 2010 through 2014. Compound annual growth rates (CAGR) are provided for the 2006-2010, 2010-2014 and 2006-2014.
Buy Now: Market Research

Related Reports

at